Regulasyon Brosur Katalogu Referansları

EcN Kapsül Broşür Referans

Print
1. Cichon C et al. DNA-Microarray-based comparison of cellular responses in polarized T84 epithelial cells triggered by probiotics: E. coli Nissle 1917 (EcN) and Lactobacillus acidophilus PZ1041. Gastroenterology 2004; 126(4): A-578.
2. Zyrek AA et al. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCz redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 2007; 9: 804–816.
3. Ukena SN et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLOS ONE 2007; 12: e1308; 1–9.
4. Kruis W, et al. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. Int J Colorectal Dis. 2012 Apr;27(4):467-74.
5. Möllenbrink M, Bruckschen E. Behandlung der chronischen Obstipation mit physiologischen Escherichia-coli-Bakterien. Med Klin 1994; 89:587–593
6. Sonnenborn U, Jürgen S. " The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic. Microbial Ecology in Health and Disease. 2009; 21(3-4), 122-158.
7. Grozdanov L et al. A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol 2002; 184: 5912–5925
8. Grozdanov L et al. Analysis of the Genome Structure of the Nonpathogenic Probiotic Escherichia coli Strain Nissle 1917 J Bacteriol. 2004; 186: 5432–5441.
9. Masjedizadeh AR, et al. Efficacy of probiotics for prevention of small intestinal bacterial overgrowth (SIBO) recurrence among patients with irritable bowel syndrome (IBS). Afro-Egyptian Journal of Infectious and Endemic Diseases. 2020;0(0):0–0.
10. Beckers M, et al. Berlin bowel bothers: Might Adolf Hitler’s gut problems have been parkinson-related? European Neurology. 2023;86(3):222–7.
11. EcN Kapsül Kitapçık

ntbiotic Kapsül Brosur Referansları

nt-biotic-kapsul
1. Vetvicka V, Vannucci L, Sima P, Richter J. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials. Molecules. 2019 Mar 30;24(7):1251.
2. Han et al. Oral administration of yeast β-glucan ameliorates inflammation and intestinal barrier in dextran sodium sulfate-induced acute colitis. Journal of Functional Foods 35 (2017) 115–126
3. Kubota A et al. Lactobacillus strains stabilize intestinal microbiota in japanese cedar pollinosis patients. Microbiol Immunol. 2009-53(4): 198-205.
4. Ouwehand AC. A review of dose-responses of probiotics in human studies. Benef Microbes. 2017 Apr 26;8(2):143-1519
5. Ritchie ML et. al. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLaS One. 20127(4)e34938.

ntflora® Intense Kapsül Broşür Referans

nt-flora-intense-kapsul
1. Kubota A et al. Lactobacillus strains stabilize intestinal microbiota in japanese cedar pollinosis patients. Microbiol Immunol. 2009-53(4): 198-205.
2. Spaiser SI et al. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. | Am Coll Nutr: 2015,34(6):459-69.
3. Ouwehand AC. A review of dose-responses of probiotics in human studies. Benef Microbes. 2017 Apr 26;8(2):143-1519
4. Ritchie ML et. al. A meta-analysis of probiotic efcacy for gastrointestinal diseases. PLoS One. 2012;7(4):e34938.
5. Miyazima TY et al. Cheese supplemented with probiotics reduced the Candida levels in denture wearers-RCT. Oral Dis. 2017 Oct,23(7):919-925.
6. Pedersen N, Andersen NN, Végh Z, Jensen L, Ankersen DV, Felding M, Simonsen MH, Burisch J, Munkholm P. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol. 2014 Nov 21;20(43):16215-26.
7. Kommers MJ et al. Effects of Probiotic Use on Quality of Life and Physical Activity in Constipated Female University Students: A Randomized, Double-Blind Placebo-Controlled Study, | Altern Complement Med. 2019,25(12): 1163-1171
8. Yoon JY, et al. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study. Dig Dis Sci. 2018-63(10):2754-2764.
9. Steenbergen L et al. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015;48.258-64.
10. Gomes AC et al. The additional effects of a probiotic mix on abdominal adiposity and antioxidant Status: A double-blind, randomized trial. Obesity (Silver Spring). 2017;25(1):30-38.
11. Deguchi R, et al. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. J Gastroenterol Hepatol. 2012 May;27(5):888-92.
12. Manley KJ, et al. Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med | Aust. 2007;186(9):454-7.
13. Ouwehand AC et al. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol. 2009,15(26):3261-8.
14. Sabico Set al. Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naive T2DM patients: a randomized clinical trial. | Transl Med. 2017;15(1)-249.

Lactoferrin Assos Kapsül Broşür Referans

Lactoferrin_Assos_Kapsul
1. Superti F. Lactoferrin from Bovine Milk: A protective companion for life. Nutrients. 2020;12(9):2562.
2. Mayeur S et al. Lactoferrin, a pleiotropic protein in health and disease. Antioxidants; Redox Signaling. 2016;24(14):813-36.
ASRAP